GLPwatch
Trials (2095)
GLP-1 clinical trials from ClinicalTrials.gov, refreshed daily.
- Fibrosis Lessens After Metabolic Surgery
- Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
- A Study of LY3457263 in Obese Participants
- 16-week Flexible vs. 8-week Semaglutide Titration
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
- Comparison of Body Weight Change Through Different Smeglutide Administration Methods
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Incretin and KATP Channels
- A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
- Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
- Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)
- Oral Semaglutide in Patients With Alzheimer's Disease
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
- Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
- Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
- Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
- Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- Daily Liraglutide for Nicotine Dependence
- Exenatide for Treating Cocaine Use Disorder
- Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
- Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
- Anti-obesity Pharmacotherapy and Inflammation
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
- WEgovy Real World Assessment of Weight Loss in Korea
- Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
- Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
- A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
- Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
- SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
- The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity
- Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
- A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
- Polycystic Ovary Syndrome and Liraglutide
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes